Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Bristol-Myers Squibb (5)
Angiotech International (4)
IPXMEDICAL, LLC (4)
Poly-Med (4)
Regents of the University of California, The (3)
NA (3)
Merrell Dow Pharmaceuticals (3)
Pfizer (2)
Massachusetts Institute Of Technology (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
Children's Medical Center (2)
Thomas Jefferson University (2)
Eisai Co. (2)
The Johns Hopkins University (2)
The United States of America as represented by the Department of Health (2)
PG-TXL (1)
Matrix Pharmaceutical (1)
Phanos Technologies (1)
Advanced cardiovascular Systems (1)
McGill University (1)
Hospira (1)
Procter & Gamble (1)
Tapestry Pharmaceuticals (1)
HOSTETLER, KARL Y. (1)
Vestar (1)
Regents Of The University of Minnesota (1)
COOK MEDICAL TECHNOLOGIES (1)
Rhone-Poulenc Rorer (1)
ANGIODEVICE INTERNATIONAL (1)
SPEED GEL (1)
COVALON technology (1)
AMO UPPSALA AB (1)
Chimerix (1)
Vertex Pharmaceuticals (1)
HOSTETLER FAMILY TRUST (1)
Celgene (1)
Montana State University (1)
Chemex Pharmaceuticals (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
Samyang (5)
ANGIODEVICE INTERNATIONAL (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (18)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
resurge therapeutics (4)
Industrial Technology research Institute (2)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
Cardiac Pacemakers (2)
COOK MEDICAL TECHNOLOGIES (2)
Covidien (2)
Broncus Technologies (2)
SWEET, RICHARD M. (2)
dfb soria ll (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Otago Innovation (1)
University of Kentucky Research Foundation (1)
Omeros (1)
Abbott Laboratories (1)
Remon Medical Technologies (1)
Bristol-Myers Squibb (1)
critltech (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7